EVGN
Income statement / Annual
Last year (2023), Evogene Ltd.'s total revenue was $5.64 M,
an increase of 236.72% from the previous year.
In 2023, Evogene Ltd.'s net income was -$23.88 M.
See Evogene Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$5.64 M
|
$1.68 M
|
$930,000.00
|
$1.04 M
|
$753,000.00
|
$1.75 M
|
$3.38 M
|
$6.54 M
|
$11.13 M
|
$14.51 M
|
| Cost of Revenue |
$4.24 M |
$909,000.00 |
$767,000.00 |
$574,000.00 |
$334,000.00 |
$1.45 M |
$2.85 M |
$5.64 M |
$8.26 M |
$9.71 M |
| Gross Profit |
$1.40 M |
$766,000.00 |
$163,000.00 |
$466,000.00 |
$419,000.00 |
$295,000.00 |
$536,000.00 |
$901,000.00 |
$2.87 M |
$4.80 M |
| Gross Profit Ratio |
0.25 |
0.46 |
0.18 |
0.45 |
0.56 |
0.17 |
0.16 |
0.14 |
0.26 |
0.33 |
| Research and Development
Expenses |
$18.11 M
|
$20.79 M
|
$23.86 M
|
$19.96 M
|
$17.82 M
|
$16.77 M
|
$18.67 M
|
$18.10 M
|
$16.41 M
|
$15.87 M
|
| General & Administrative
Expenses |
$8.67 M
|
$6.48 M
|
$7.25 M
|
$5.32 M
|
$3.77 M
|
$3.51 M
|
$3.81 M
|
$3.89 M
|
$4.38 M
|
$4.19 M
|
| Selling & Marketing
Expenses |
$1.01 M
|
$3.93 M
|
$653,000.00
|
$520,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$9.68 M
|
$10.42 M
|
$7.25 M
|
$5.32 M
|
$3.77 M
|
$3.51 M
|
$3.81 M
|
$3.89 M
|
$4.38 M
|
$4.19 M
|
| Other Expenses |
$0.00 |
-$3.50 M |
$0.00 |
$15.02 M |
-$41,000.00 |
-$120,000.00 |
-$67,000.00 |
-$33,000.00 |
$0.00 |
-$231,000.00 |
| Operating Expenses |
$27.79 M |
$27.71 M |
$31.12 M |
$25.28 M |
$21.59 M |
$20.28 M |
$22.48 M |
$21.99 M |
$20.80 M |
$20.06 M |
| Cost And Expenses |
$32.03 M |
$28.62 M |
$31.88 M |
$25.85 M |
$21.92 M |
$21.74 M |
$25.33 M |
$27.63 M |
$29.05 M |
$29.77 M |
| Interest Income |
$1.25 M |
$516,000.00 |
$1.94 M |
$1.59 M |
$2.46 M |
$1.41 M |
$2.13 M |
$2.42 M |
$2.57 M |
$2.24 M |
| Interest Expense |
$171,000.00 |
$3.33 M |
$1.41 M |
$2.95 M |
$386,000.00 |
$2.21 M |
$1.01 M |
$891,000.00 |
$1.86 M |
$1.52 M |
| Depreciation &
Amortization |
$2.61 M
|
$2.58 M
|
$2.23 M
|
$2.73 M
|
$2.77 M
|
$2.02 M
|
$2.15 M
|
$2.28 M
|
$2.43 M
|
$2.25 M
|
| EBITDA |
-$23.20 M
|
-$26.93 M
|
-$27.80 M
|
-$23.18 M
|
-$15.97 M
|
-$18.62 M
|
-$18.55 M
|
-$18.81 M
|
-$15.49 M
|
-$13.01 M
|
| EBITDA Ratio |
-4.11 |
-14.24 |
-28.8 |
-19.71 |
-21.16 |
-9.48 |
-5.23 |
-2.85 |
-1.38 |
-0.9 |
| Operating Income Ratio
|
-4.68
|
-16.08
|
-33.28
|
-23.86
|
-28.11
|
-11.44
|
-6.49
|
-3.22
|
-1.61
|
-1.05
|
| Total Other
Income/Expenses Net |
$404,000.00
|
$687,000.00
|
$521,000.00
|
-$1.36 M
|
$2.08 M
|
-$793,000.00
|
-$1.73 M
|
$1.53 M
|
$708,000.00
|
$726,000.00
|
| Income Before Tax |
-$25.99 M |
-$29.75 M |
-$30.43 M |
-$26.17 M |
-$19.09 M |
-$20.78 M |
-$20.83 M |
-$19.56 M |
-$17.21 M |
-$14.53 M |
| Income Before Tax Ratio
|
-4.61
|
-17.76
|
-32.72
|
-25.17
|
-25.35
|
-11.9
|
-6.16
|
-2.99
|
-1.55
|
-1
|
| Income Tax Expense |
-$33,000.00 |
$90,000.00 |
$13,000.00 |
$32,000.00 |
$24,000.00 |
$30,000.00 |
$11,000.00 |
$36,000.00 |
-$2.20 M |
-$1.80 M |
| Net Income |
-$23.88 M |
-$26.64 M |
-$27.79 M |
-$23.37 M |
-$18.11 M |
-$20.76 M |
-$20.84 M |
-$19.59 M |
-$17.21 M |
-$14.53 M |
| Net Income Ratio |
-4.23 |
-15.9 |
-29.88 |
-22.48 |
-24.05 |
-11.88 |
-6.16 |
-3 |
-1.55 |
-1 |
| EPS |
-5.23 |
-6.46 |
-6.87 |
-8.3 |
-0.7 |
-0.81 |
-0.81 |
-0.77 |
-0.68 |
-0.58 |
| EPS Diluted |
-5.23 |
-6.46 |
-6.87 |
-8.3 |
-0.7 |
-0.81 |
-0.81 |
-0.77 |
-0.68 |
-0.58 |
| Weighted Average Shares
Out |
$4.57 M
|
$4.12 M
|
$4.04 M
|
$2.82 M
|
$25.75 M
|
$25.75 M
|
$25.73 M
|
$25.44 M
|
$25.31 M
|
$25.05 M
|
| Weighted Average Shares
Out Diluted |
$4.57 M
|
$4.12 M
|
$4.04 M
|
$2.82 M
|
$25.75 M
|
$25.75 M
|
$25.73 M
|
$25.44 M
|
$25.31 M
|
$25.05 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
